Any hopes of a last minute reprieve for countries facing tough US tariffs ended at midnight in Washington as Trump’s reciprocal levies kicked in, with the 104% on Chinese goods the highest.
Whether it’s viewed as rebalancing trading relationships to make it fairer for the US, or the highest tax rise on US citizens for decades, for global economies and American businesses the impact is real, and investors are taking it badly.
Tariffs are the driver of a 12% drop in the Dow Jones Industrial Average over four days, that’s 4,500 points lost, closing 0.9% lower Tuesday while the S&P 500 ended its session down 1.6% having been up 4% earlier in the day.
US futures indicate a flat start to the new day, but global equities are down with Europe off by around 3% and Asian markets mixed, with China notably higher despite the eyewatering tariffs amid fighting talk from Beijing, while also showing willingness to negotiate with the US.
But while the markets navigate the muddied waters of global trade, there may yet be further industry-specific tariffs to come.
President Trump said Tuesday that “We are going to be announcing very shortly a major tariff on pharmaceuticals.” The industry was one of those highlighted previously with the president annoyed that many US pharma firms have established themselves in the Republic of Ireland where corporate taxes are low.
While no details have been provided regarding potential rates of tariffs on pharmaceutical imports, those for auto, steel, and aluminium have been set at 25% which could be repeated for the drugmakers.
“Once we do that, they’re going to come rushing back into our country, because we’re the big market,” Trump told a Republican fundraiser. “The advantage we have over everybody is that we’re the big market.”
The bank has swiped three private banking veterans from BNY as the city climbs the ranks of America's fastest-growing wealth hubs.
Employee accounts, crypto trials and job cuts frame a pivotal year for the Swiss lender.
New name draws on founder's family history as consolidation reshapes the broker-dealer landscape.
Deal brings tech-focused planning expertise, expanded Pacific Northwest presence to national RIA platform.
Five low-cost index ETFs to anchor Trump Accounts as advisors weigh options against 529 and UTMA plans for clients
Dan Biagini of American Equity says the steady decline of pensions, longer lifespans and a reset in interest rates are rewriting how advisors build retirement income
Direct indexing is on pace to outgrow ETFs and mutual funds. Northern Trust's Ken Lassner explains why the advisors who get it wish they had started sooner.